GAPDH and diffuse large B-cell lymphoma: A distinctive property of glyceraldehyde-3-phosphate dehydrogenase is its capability to assess DLBCL patients undergoing R-CHOP treatment and serve as a reliable independent indicator for predicting enhanced prognosis among patients[21] (Fig. 1).